MedTrace Logo

Developing an Interdisciplinary Pharmacogenomic Treatment Approach to Reduce Medication Burden and Improve Outcomes

NCT01274065 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2015-01-14

No results posted yet for this study

Summary

There is no common rule as to how a drug will affect patients. This is due to the effect specific DNA sequences of genes have on drug response, by the effect they have on how medications are metabolized. The primary objective of this research is to optimize medication therapy and to reduce the number of medications used, specifically medications for people with developmental disabilities and co-occuring psychiatric illnesses.

Conditions

  • Developmental Disabilities

Interventions

GENETIC

Genetic analysis

The research team will review data following DNA sample analysis and identify variants in genes that result in impaired drug metabolism

Sponsors & Collaborators

  • Avera McKennan Hospital & University Health Center

    lead OTHER

Principal Investigators

  • Timothy Soundy, MD · Avera McKennan Hospital & University Health Center

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2014-11-30
Completion
2014-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01274065 on ClinicalTrials.gov